C.M. Woodroffe
Walsall Manor Hospital · 15 works · 916 citations · h-index 11
Top works
- Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life
- Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare
- Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: A randomised, controlled trial
- Long-term toxicity of chemotherapy for testicular cancer – the cost of cure
- Testing new drugs in untreated small cell lung cancer may prejudice the results of standard treatment: a phase II study of oral idarubicin in extensive disease.
- ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group.
- Quality of life after treatment for testicular cancer—the patient's view
- The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial
- 26 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 3. Results of a randomised trial evaluating palliation & quality of life
- Chemotherapy for Poor Risk Germ Cell Tumours An Independent Evaluation of the POM B/ACE Regime
- 10 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 1. Results of a randomised trial in patients with localised, inoperable disease
- 11 Mitomycin, ifosfamide and cisplatin (MIC) in non-small cell lung cancer (NSCLC): 2. Results of a randomised trial in patients with extensive disease
- Ifosfamide, mitomycin and radiotherapy in non-small-cell lung cancer
- Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin’s lymphoma
- A case of spontaneous regression of metastatic testicular teratoma